Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (5 ops.)
Latest filing published 12 Aug 2026 for PFIZER INC, €867k.
Filing timeline
BuySaleAlbert Bourla
Insider track record
Disclosed buys
1
Disclosed sells
5
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +10.4%Entry US$26.80 · Close 16 Oct 2026 US$29.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Albert Bourla: trading record in brief
The latest trade in the record of Albert Bourla is a purchase: EUR 867,197 on August 12, 2026 at Pfizer Inc, where Albert Bourla appears as Chairman & CEO. It is the only purchase in the record, which also holds 5 sales worth EUR 5.2 million, median EUR 154,414.
One sale dominates: EUR 4,672,817 on November 9, 2020. The next two are both dated November 4, 2016, for EUR 294,830 and EUR 154,414. The rest of the 61 filings, published from February 26, 2016 to August 12, 2026, consists of 36 grants and 19 option exercises.
Activity is strongest in 2016 (9 filings), then in 2019 and 2020 (7 each). It drops to 8 filings in 2021 and in 2024. Four filings sit in the last twelve months, the purchase among them.
4, 1 and 1 trades by Bourla fall within 30 days of colleagues at Pfizer Inc, in that order. All on the same side. Colleagues in order: Anthony J. Maddaluna, Mortimer J. Buckley and Ronald E. Blaylock. The median publication delay is 3 days.
Companies and markets linked to Albert Bourla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations61 total
38,000 shares@ US$26.340.0006% mcap1.6% of flowCommon StockSEC:0001225208-26-007083:0
Canonical exit: 10 Nov 2026 (T+90)
8,303 shares@ US$27.090.2% of flowCommon StockSEC:0001225208-26-002818:1
467,241 shares@ US$26.928.7% of flowCommon StockSEC:0001225208-26-002818:2
491,626 shares@ US$33.8225.8% of flowCommon StockSEC:0001225208-26-002818:0
18,300 shares@ US$26.100.4% of flowCommon StockSEC:0001225208-25-002703:1
545,855 shares@ US$26.0611.0% of flowCommon StockSEC:0001225208-25-002703:2
582,823 shares@ US$31.3131.7% of flowCommon StockSEC:0001225208-25-002703:0
8,835 shares@ US$26.300.2% of flowCommon StockSEC:0001225208-25-002402:1
212,680 shares@ US$26.084.3% of flowCommon StockSEC:0001225208-25-002402:2
238,399 shares@ US$30.1712.5% of flowCommon StockSEC:0001225208-25-002402:0
8,831 shares@ US$27.760.2% of flowCommon StockSEC:0001225208-24-003049:1
103,178 shares@ US$27.372.1% of flowCommon StockSEC:0001225208-24-003049:2
127,674 shares@ US$27.345.9% of flowCommon StockSEC:0001225208-24-003049:0
43,419 shares@ US$41.753.1% of flowCommon StockSEC:0001225208-23-002918:0
61,994 shares@ US$42.384.5% of flowCommon StockSEC:0001225208-23-002808:0
89,156 shares@ US$22.891.6% of flowCommon StockSEC:0001225208-22-012885:1
133,172 shares@ US$30.176.9% of flowCommon StockSEC:0001225208-22-012885:0
21,824 shares@ US$47.721.7% of flowCommon StockSEC:0001225208-22-003661:0
37,509 shares@ US$46.872.8% of flowCommon StockSEC:0001225208-22-003460:0
42,975 shares@ US$25.601.1% of flowCommon StockSEC:0001225208-21-015181:1
80,080 shares@ US$27.343.5% of flowCommon StockSEC:0001225208-21-015181:0
53,925 shares@ US$22.351.1% of flowCommon StockSEC:0001225208-21-004300:0
9,664 shares@ US$33.490.3% of flowCommon StockSEC:0001225208-21-004300:1
34,191 shares@ US$34.641.1% of flowCommon StockSEC:0001225208-21-004300:2
163,334 shares@ US$22.863.5% of flowCommon StockSEC:0001225208-21-004031:0
25 of 61 declarations
